The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations.
about
Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity.Feedback activation of neurofibromin terminates growth factor-induced Ras activation.Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer.Mechanistic modeling to investigate signaling by oncogenic Ras mutants.Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinations.Quantitative Systems Pharmacology Analysis of KRAS G12C Covalent Inhibitors.
P2860
The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The impact of the regulatory d ...... n towards oncogenic mutations.
@en
The impact of the regulatory d ...... n towards oncogenic mutations.
@nl
type
label
The impact of the regulatory d ...... n towards oncogenic mutations.
@en
The impact of the regulatory d ...... n towards oncogenic mutations.
@nl
prefLabel
The impact of the regulatory d ...... n towards oncogenic mutations.
@en
The impact of the regulatory d ...... n towards oncogenic mutations.
@nl
P2093
P2860
P1433
P1476
The impact of the regulatory d ...... n towards oncogenic mutations.
@en
P2093
Frank Tobin
Igor Goryanin
Serge Dronov
P2860
P304
P356
10.1111/J.1742-4658.2007.06066.X
P407
P577
2007-10-04T00:00:00Z